Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Share-based Compensation Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -1.05% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 32.51% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.86% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.74% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -7.98% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 71.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.54% |
| Mar 31, 2026 | -37.20% |
| Dec 31, 2025 | -34.95% |
| Sep 30, 2025 | -51.75% |
| Jun 30, 2025 | -55.72% |
| Mar 31, 2025 | -62.52% |
| Dec 31, 2024 | -22.81% |
| Sep 30, 2024 | -56.84% |
| Jun 30, 2024 | -58.03% |
| Mar 31, 2024 | -62.68% |
| Dec 31, 2023 | -21.09% |
| Sep 30, 2023 | -46.83% |
| Jun 30, 2023 | -46.44% |
| Mar 31, 2023 | 48.43% |
| Dec 31, 2022 | 49.36% |
| Sep 30, 2022 | 59.25% |
| Jun 30, 2022 | 59.25% |
| Mar 31, 2022 | 190.48% |
| Dec 31, 2021 | 39.46% |
| Sep 30, 2021 | 213.88% |